Skip to Main Content
hidden1hidden2
hidden1hidden2
hidden1hidden2

Our ambition is to transform our business to become a global leader in sustainable healthcare

hidden1hidden2
hidden1hidden2

Materiality Analysis

Following a materiality analysis in 2021, we launched WeCare. Based on the Paris Agreement and the UN Sustainable Development Goals, WeCare embeds social, environmental, and economic value for patients and healthcare providers across our product and service offering. It also directs how we conduct our business in the short, mid and long-term to create a sustainable, equitable and inclusive future.

hidden1hidden2
hidden1hidden2
hidden1hidden2

Milestones on the way to Net Zero

2016: Scope 1 and 2 GHG emissions measured and baseline established.
2021: Materiality analysis and development of WeCare (2030 sustainability roadmap).
2021: Upstream and downstream scope 3 GHG emissions measured and baseline established.
2021: First range of BARRIER® surgical drapes launched with demonstrable reductions in emissons.
2022: Commitment to SBTi and nine manufacturing sites operating on 100% fossil-free electricity.
2023: Validation of near-term GHG emission reduction targets by SBTi.
2023: Sustainable Product Portfolio Assessment conduced for Operation Room Solutions and Antiseptics portfolios.

hidden1hidden2

Ethical business

We set high standards of ethics and responsibility in our business. We continuously improve our compliance framework supported by an embedded integrity mindset throughout the organization. We expect all of our employees to act with integrity, complying with laws, regulations and industry requirements, considering the impact of their actions and making ethical business decisions. We continuously improve our compliance framework supported by an embedded integrity mindset throughout the organization.

hidden1hidden2
hidden1hidden2
hidden1hidden2